Zhi Mou - Immage Biotherapeutics CEO

CEO

Mr. Zhi Cong Mou is President, Chief Executive Officer, Treasurer, Secretary, Director of the Company. He President, Treasurer, Secretary, Director of the Company. He is President . Since March 2012, Mr. Mou was the Accounts Director for Nanning Business Consulting Co., GuanXi, China company engage in the business of account auditing. From June 2009 through February 2012, Mr. Mou worked as the Accounts Manager for Nanning Business Consulting Co. Prior to that, from February 2004 through February 2007, Mr. Mou was an inhouse company accountant for Yongjian Engineering Co., Ltd., a GuanXi, China company engaged in the business of civil construction. since 2015.
Age 40
Tenure 9 years
Phone866-692-2939
Webhttp://www.immagebio.com

Immage Biotherapeutics Management Efficiency

The company has return on total asset (ROA) of (4.9611) % which means that it has lost $4.9611 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.3357) %, meaning that it created substantial loss on money invested by shareholders. Immage Biotherapeutics' management efficiency ratios could be used to measure how well Immage Biotherapeutics manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Found 6 records

CEO Age

Mark BristowBarrick Gold Corp
61
Dale AndresGatos Silver
56
D BristowBarrick Gold Corp
61
Gerard GuillemotUbiSoft Entertainment
62
Stephen OrrGatos Silver
65
Thomas HillVulcan Materials
59
Immage Biotherapeutics Corp. does not have significant business operations. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited. IMMAGE BIOTHERAPEUTICS is traded on OTC Exchange in the United States. Immage Biotherapeutics Corp (IMMG) is traded on OTCCE Exchange in USA and employs 3 people.

Management Performance

Immage Biotherapeutics Leadership Team

Elected by the shareholders, the Immage Biotherapeutics' board of directors comprises two types of representatives: Immage Biotherapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Immage. The board's role is to monitor Immage Biotherapeutics' management team and ensure that shareholders' interests are well served. Immage Biotherapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Immage Biotherapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Daniel Achinko, VP of Bioformatics
MS MD, Chairman and Chief Scientific Officer
Mahesh Narayanan, COO and Director
Elton Norman, CFO, Director
Anton Dormer, Chairman of the Board, Chief Scientific Officer
CPA JD, CFO and Director
Zhi Mou, CEO and President Treasurer, Secretary and Director

Immage Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Immage Biotherapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in Immage Stock

If you are still planning to invest in Immage Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immage Biotherapeutics' history and understand the potential risks before investing.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format